Company intelligence / Profile preview

GeneFerm Biotechnology

Ownership: Private
Development stage: Commercial

Overview

GeneFerm is a leading provider of microbial fermentation-based manufacturing and functional food ingredients, with a focus on health supplements. The company has developed proprietary strains and processes for producing bioactive compounds such as nattokinase, red yeast rice powder, various mycelia powders, beta-glucan, probiotics, and peptide ingredients. At least one clinical program is pending for the use of nattokinase in hyperlipidemias

Therapeutic areas: Cardiovascular
Modalities: Microbial therapyProbioticsPeptidesEnzyme (e.g., nattokinase)
Industry: Non-Drug Biotech

Drug pipeline

1 asset

GFRena2

Commercial

Indications: Circulatory health, Gut health

Partnerships

Provides toll manufacturing services to international pharmaceutical, biotech, and food companies

Beyond the preview

Go deeper on GeneFerm Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneFerm Biotechnology.

Explore the full profile